L-carnitine as primary or adjuvant treatment in infertile patients with varicocele. A systematic review

Submitted: May 28, 2020
Accepted: June 8, 2020
Published: October 2, 2020
Abstract Views: 1512
PDF: 698
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Background: Varicocele has been found to impair the function of the epididymis resulting in subfertility whereas the varicocelectomy can resolve the phenomenon. L-carnitine is regarded as a biomarker for the function of the epididymis and has been found in reduced concentrations in infertile patients of various causes, including infertile men with varicocele. It seems that Lcarnitine and varicocele share clinical significance and the area of research looks promising.
Objective: To identify the role of L-carnitine in the treatment of varicocele.
Materials and methods: A systematic search was performed in Pubmed/Medline with the terms (L-carnitine) and (varicocele) and (L-carnitine) and (varicocelectomy). Inclusion criteria were studies reported outcomes of L-carnitine administration alone or in duet, as primary or adjuvant treatment to varicocele. Exclusion criteria were non-English language and animal studies. Studies using L-carnitine as part of a panel of therapeutic agents were avoided.
Results: Only four suitable studies were identified for discussion. In one randomized study, the combination of L-carnitine and cinnoxicam improved semen parameters in patients with non-high-grade varicocele compared to L-carnitine alone and had a favourable effect on pregnancy rates but the effect of grade is unknown. In another study, as an adjuvant treatment to varicocelectomy, L-carnitine showed no clear benefit. Finally, in comparison to surgery, the results are inconclusive; two studies showed some benefit might be expected in low-grade or subclinical varicocele, but surgery appears superior.
Conclusions: The evidence regarding the role of L-carnitine as a primary or adjuvant treatment of varicocele is sparse. The pathophysiological significance of L-carnitine implicates a potential role of the molecule in the management of varicocele, but the evidence so far is controversial for any recommendations. L-carnitine might be taken into consideration in selected cases; however, further search is needed in order the optimal role of L-carnitine in infertile patients with varicocele to be clarified.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

A. Agarwal, R. Sharma, A. Harlev, and S. Esteves, “Effect of varicocele on semen characteristics according to the new 2010 World Health Organization criteria: a systematic review and meta-analysis,” Asian J. Androl., vol. 18, no. 2, p. 163, 2016, doi: 10.4103/1008-682X.172638. DOI: https://doi.org/10.4103/1008-682X.172638
X. Wan, H. Wang, and Z. Ji, “Microsurgical varicocelectomy for clinical varicocele: A review for potential new indications.,” Andrologia, vol. 49, no. 10, Dec. 2017, doi: 10.1111/and.12827. DOI: https://doi.org/10.1111/and.12827
N. Erfani Majd, N. Sadeghi, M. Tavalaee, M. R. Tabandeh, and M. H. Nasr-Esfahani, “Evaluation of Oxidative Stress in Testis and Sperm of Rat Following Induced Varicocele.,” Urol. J., vol. 16, no. 3, pp. 300–306, Jun. 2019, doi: 10.22037/uj.v0i0.4740.
K. Lorian et al., “Long-term NaHS administration reduces oxidative stress and apoptosis in a rat model of left-side varicocele.,” Andrologia, p. e13496, Dec. 2019, doi: 10.1111/and.13496. DOI: https://doi.org/10.1111/and.13496
M. I. Omar et al., “Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis.,” Eur. Urol., vol. 75, no. 4, pp. 615–625, Apr. 2019, doi: 10.1016/j.eururo.2018.12.022. DOI: https://doi.org/10.1016/j.eururo.2018.12.022
E. A. Nada, M. A. El Taieb, H. M. Ibrahim, and A. E.-R. A. Al Saied, “Efficacy of tamoxifen and l-carnitine on sperm ultrastructure and seminal oxidative stress in patients with idiopathic oligoasthenoteratozoospermia.,” Andrologia, vol. 47, no. 7, pp. 801–810, Sep. 2015, doi: 10.1111/and.12333. DOI: https://doi.org/10.1111/and.12333
A. Majzoub and A. Agarwal, “Systematic review of antioxidant types and doses in male infertility: Benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate.,” Arab J. Urol., vol. 16, no. 1, pp. 113–124, Mar. 2018, doi: 10.1016/j.aju.2017.11.013. DOI: https://doi.org/10.1016/j.aju.2017.11.013
L. Mongioi et al., “The role of carnitine in male infertility.,” Andrology, vol. 4, no. 5, pp. 800–807, Sep. 2016, doi: 10.1111/andr.12191. DOI: https://doi.org/10.1111/andr.12191
S. Banihani, A. Agarwal, R. Sharma, and M. Bayachou, “Cryoprotective effect of L-carnitine on motility, vitality and DNA oxidation of human spermatozoa.,” Andrologia, vol. 46, no. 6, pp. 637–641, Aug. 2014, doi: 10.1111/and.12130. DOI: https://doi.org/10.1111/and.12130
U. Wetterauer and H. J. Heite, “Carnitine in seminal plasma: its significance in diagnostic andrology.,” Arch. Androl., vol. 4, no. 2, pp. 137–143, Mar. 1980, doi: 10.3109/01485018008986480. DOI: https://doi.org/10.3109/01485018008986480
L. M. Lewin, D. P. Shalev, R. Weissenberg, and Y. Soffer, “Carnitine and acylcarnitines in semen from azoospermic patients.,” Fertil. Steril., vol. 36, no. 2, pp. 214–218, Aug. 1981. DOI: https://doi.org/10.1016/S0015-0282(16)45681-5
M. De Rosa et al., “Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins.,” Drugs R. D., vol. 6, no. 1, pp. 1–9, 2005, doi: 10.2165/00126839-200506010-00001. DOI: https://doi.org/10.2165/00126839-200506010-00001
G. Cavallini, A. P. I. A. Ferraretti, L. Gianaroli, G. Biagiotti, and G. Vitali, “Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia,” J. Androl., vol. 25, no. 5, pp. 761–770, 2004, doi: 10.1002/j.1939-4640.2004.tb02853.x. DOI: https://doi.org/10.1002/j.1939-4640.2004.tb02853.x
H. Sofimajidpour, E. Ghaderi, and O. Ganji, “Comparison of the Effects of Varicocelectomy and Oral L-carnitine on Sperm Parameters in Infertile Men with Varicocele.,” J. Clin. Diagn. Res., vol. 10, no. 4, pp. PC07-10, Apr. 2016, doi: 10.7860/JCDR/2016/18464.7557.
J. T. Seo, K. T. Kim, M. H. Moon, and W. T. Kim, “The significance of microsurgical varicocelectomy in the treatment of subclinical varicocele,” Fertil. Steril., vol. 93, no. 6, pp. 1907–1910, 2010, doi: 10.1016/j.fertnstert.2008.12.118. DOI: https://doi.org/10.1016/j.fertnstert.2008.12.118
G. Pourmand et al., “Does L-carnitine therapy add any extra benefit to standard inguinal varicocelectomy in terms of deoxyribonucleic acid damage or sperm quality factor indices: a randomized study.,” Urology, vol. 84, no. 4, pp. 821–825, Oct. 2014, doi: 10.1016/j.urology.2014.07.006. DOI: https://doi.org/10.1016/j.urology.2014.07.006
U. Wetterauer and H. J. Heite, “Carnitine in seminal fluid as parameter for the epididymal function.,” Andrologia, vol. 10, no. 3, pp. 203–210, 1978, doi: 10.1111/j.1439-0272.1978.tb03017.x. DOI: https://doi.org/10.1111/j.1439-0272.1978.tb03017.x
S. D. Milingos, “The epididymal factor--a diagnostic approach.,” Int. J. Androl., vol. 8, no. 6, pp. 417–420, Dec. 1985, doi: 10.1111/j.1365-2605.1985.tb00854.x. DOI: https://doi.org/10.1111/j.1365-2605.1985.tb00854.x
A. Lenzi, F. Lombardo, L. Gandini, and F. Dondero, “[Metabolism and action of L-carnitine: its possible role in sperm tail function].,” Arch. Ital. Urol. Nefrol. Androl., vol. 64, no. 2, pp. 187–196, Jun. 1992.
B. Gurbuz, S. Yalti, C. Ficicioglu, and K. Zehir, “Relationship between semen quality and seminal plasma total carnitine in infertile men.,” J. Obstet. Gynaecol., vol. 23, no. 6, pp. 653–656, Nov. 2003, doi: 10.1080/01443610310001604466. DOI: https://doi.org/10.1080/01443610310001604466
I. Matalliotakis, Y. Koumantaki, A. Evageliou, G. Matalliotakis, A. Goumenou, and E. Koumantakis, “L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality.,” Int. J. Fertil. Womens. Med., vol. 45, no. 3, pp. 236–240, 2000.
G. Vivas-Acevedo, R. Lozano-Hernandez, and M. I. Camejo, “Markers of accessory sex glands function in men with varicocele, relationship with seminal parameters.,” Can. J. Urol., vol. 18, no. 5, pp. 5884–5889, Oct. 2011.
K. Zhang, Z. Wang, H. Wang, Q. Fu, H. Zhang, and Q. Cao, “Hypoxia-induced apoptosis and mechanism of epididymal dysfunction in rats with left-side varicocele.,” Andrologia, vol. 48, no. 3, pp. 318–324, Apr. 2016, doi: 10.1111/and.12449. DOI: https://doi.org/10.1111/and.12449
M. Lehtihet, S. Arver, B. Kalin, U. Kvist, and A. Pousette, “Left-sided grade 3 varicocele may affect the biological function of the epididymis.,” Scand. J. Urol., vol. 48, no. 3, pp. 284–289, Jun. 2014, doi: 10.3109/21681805.2013.868513. DOI: https://doi.org/10.3109/21681805.2013.868513
B. Pajovic, A. Dimitrovski, N. Radojevic, and M. Vukovic, “A correlation between selenium and carnitine levels with hypo-osmotic swelling test for sperm membrane in low-grade varicocele patients.,” Eur. Rev. Med. Pharmacol. Sci., vol. 20, no. 4, pp. 598–604, 2016.
R. Henkel, I. S. Sandhu, and A. Agarwal, “The excessive use of antioxidant therapy: A possible cause of male infertility?,” Andrologia, vol. 51, no. 1, p. e13162, Feb. 2019, doi: 10.1111/and.13162. DOI: https://doi.org/10.1111/and.13162
A. Agarwal et al., “Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility.,” World J. Mens. Health, May 2019, doi: 10.5534/wjmh.190055. DOI: https://doi.org/10.5534/wjmh.190055
G. M. Busetto et al., “Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: A double-blind placebo-controlled study.,” Andrologia, vol. 50, no. 3, Apr. 2018, doi: 10.1111/and.12927. DOI: https://doi.org/10.1111/and.12927
J. Gual-Frau et al., “Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I varicocele patients.,” Hum. Fertil. (Camb)., vol. 18, no. 3, pp. 225–229, Sep. 2015, doi: 10.3109/14647273.2015.1050462. DOI: https://doi.org/10.3109/14647273.2015.1050462
H. J. Kim et al., “Clinical significance of subclinical varicocelectomy in male infertility: systematic review and meta-analysis.,” Andrologia, vol. 48, no. 6, pp. 654–661, Aug. 2016, doi: 10.1111/and.12495. DOI: https://doi.org/10.1111/and.12495
A. Cyrus, A. Kabir, D. Goodarzi, and M. Moghimi, “The effect of adjuvant vitamin C after varicocele surgery on sperm quality and quantity in infertile men: a double blind placebo controlled clinical trial.,” Int. Braz J Urol, vol. 41, no. 2, pp. 230–238, 2015, doi: 10.1590/S1677-5538.IBJU.2015.02.07. DOI: https://doi.org/10.1590/S1677-5538.IBJU.2015.02.07
S. Akdemir et al., “Different surgical techniques and L-carnitine supplementation in an experimental varicocele model.,” Andrologia, vol. 46, no. 8, pp. 910–916, Oct. 2014, doi: 10.1111/and.12172. DOI: https://doi.org/10.1111/and.12172
N. Thirumavalavan et al., “The Impact of Microsurgical Repair of Subclinical and Clinical Varicoceles on Total Motile Sperm Count: Is There a Difference?,” Urology, no. 713, pp. 1–5, 2018, doi: 10.1016/j.urology.2018.06.036. DOI: https://doi.org/10.1016/j.urology.2018.06.036

How to Cite

Tsampoukas, G., Khan, M. F., Katsouri, A., Akhter, W., Moussa, M., Deliveliotis, K., Papatsoris, A., & Buchholz, N. (2020). L-carnitine as primary or adjuvant treatment in infertile patients with varicocele. A systematic review. Archivio Italiano Di Urologia E Andrologia, 92(3). https://doi.org/10.4081/aiua.2020.3.263